Open an account

Globus Medical

GMED · NYSE

$78.96+$3.31 (+4.38%)TodayMarket closed ·
Prev close $75.65

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.

Employees
6,000
Headquarters
Audubon, Pennsylvania
Listed
Mar 8, 2012
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
globusmedical.com

GMED key statistics

Market cap
10.16B
Price-earnings ratio
19.40
Dividend yield
—
Average volume
1.52M
Volume
1.08M
Open price
$76.57
High today
$79.20
Low today
$76.17
52 Week high
$101.40
52 Week low
$58.32

Globus Medical (GMED) at a glance

Globus Medical (GMED) last traded at $78.96, with a market cap of 10.16B and a price-to-earnings ratio of 19.40.

Today the stock has traded between $76.17 and $79.20. The current price is 3.7% above the day's low and 0.3% below its high.

Volume so far is 1.08M shares, below the average of 1.52M shares a day.

Over the past year Globus Medical has ranged from $58.32 to $101.40, and now sits 48% of the way up that range.

Globus Medical met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $1.34 per share against an estimate of $1.12.

The average analyst price target is $105.06, 33.1% above the current price, from 16 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

75%of 16 analyst ratings say Buy
  • Buy75.0%
  • Hold25.0%
  • Sell0.0%
Price target · 17 analystsAvg $105.06
Low
$84.84
Now
$78.96
High
$131.25

GMED earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 20.5% on average.

  1. Q3 FY24: reported $0.83 per share against an estimate of $0.6616
  2. Q4 FY24: reported $0.84 per share against an estimate of $0.7603
  3. Q1 FY25: reported $0.68 per share against an estimate of $0.7589
  4. Q2 FY25: reported $0.86 per share against an estimate of $0.7706
  5. Q3 FY25: reported $1.18 per share against an estimate of $0.7984
  6. Q4 FY25: reported $1.28 per share against an estimate of $1.17
  7. Q1 FY26: reported $1.12 per share against an estimate of $0.9381
  8. Q2 FY26: reported $1.34 per share against an estimate of $1.12

GMED news

  • Press releaseGlobe Newswire

    Globus Medical Schedules Third Quarter Earnings Release and Conference Call

  • Press releaseGlobe Newswire

    Globus Medical Reports Second Quarter 2026 Results

  • Press releasePRNewswire

    Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm

  • Press releaseGlobe Newswire

    Globus Medical Schedules Second Quarter Earnings Release and Conference Call

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)

  • Avi Kapoor

    Jim Cramer Flags Industrial Company With 'Almost No Revenue,' Says No To Rocket Companies

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Globus Medical Reports First Quarter 2026 Results

Similar companies

Companies in the same industry as Globus Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.